Limula Biotech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5.71M

  • Investors
  • 18

Limula Biotech General Information

Description

Developer of automated cell therapy manufacturing platforms designed for scalable production. The company's platform integrates bioreactor and centrifuge functionalities into a single device, automating complex cell processing steps without human intervention, featuring in-situ centrifugation, modular design, scalability, versatility for various cell types, and an intuitive user interface, enabling biotech and pharmaceutical companies to transition from open, manual methods to closed, automated processes, improving efficiency and accessibility in cell and gene therapy manufacturing.

Contact Information

Website
www.limula.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rte de la Corniche 5
  • 1066 Epalinges
  • Switzerland
+41 044
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Corporate Office
  • Rte de la Corniche 5
  • 1066 Epalinges
  • Switzerland
+41 044

Limula Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Limula Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
21. Seed Round 21-May-2024 $5.71M Completed Generating Revenue
20. Accelerator/Incubator Completed Generating Revenue
19. Grant 16-Oct-2023 Completed Generating Revenue
18. Accelerator/Incubator 01-Jun-2023 Completed Startup
17. Grant 30-May-2023 Completed Startup
16. Grant 01-Dec-2022 Completed Startup
15. Grant 02-May-2022 Completed Startup
14. Seed Round 16-Feb-2022 Completed Startup
13. Accelerator/Incubator 16-Feb-2022 $5.91M Completed Startup
12. Grant 24-Jan-2022 $16.4K $5.91M Completed Startup
To view Limula Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Limula Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of automated cell therapy manufacturing platforms designed for scalable production. The company's platform int
Biotechnology
Epalinges, Switzerland
20 As of 2025

South San Francisco, CA
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Limula Biotech Competitors (8)

One of Limula Biotech’s 8 competitors is Cellares, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellares Venture Capital-Backed South San Francisco, CA
Ori Biotech Venture Capital-Backed London, United Kingdom
Astraveus Venture Capital-Backed Paris, France
MFX Venture Capital-Backed Stevenage, United Kingdom
Adva Biotechnology Venture Capital-Backed Ahihud, Israel
You’re viewing 5 of 8 competitors. Get the full list »

Limula Biotech Patents

Limula Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023478822-A1 Bioprocess chamber with frustum-shaped section Pending 28-Dec-2023
EP-4833293-A1 Bioprocess chamber with frustum-shaped section Pending 28-Dec-2023
WO-2025140774-A1 Bioprocess chamber with frustum-shaped section Inactive 28-Dec-2023
CA-227726-S Bioreactor vessel Active 28-Dec-2023
CA-227727-S Bioreactor vessel Active 28-Dec-2023
To view Limula Biotech’s complete patent history, request access »

Limula Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Limula Biotech Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lichtsteiner Foundation Limited Partner Minority
Life Extension Ventures Venture Capital Minority
Oxford Saïd Business School University Minority
Verve Ventures Venture Capital Minority
W. A. de Vigier Foundation Limited Partner Minority
You’re viewing 5 of 18 investors. Get the full list »

Limula Biotech FAQs

  • When was Limula Biotech founded?

    Limula Biotech was founded in 2020.

  • Where is Limula Biotech headquartered?

    Limula Biotech is headquartered in Epalinges, Switzerland.

  • What is the size of Limula Biotech?

    Limula Biotech has 20 total employees.

  • What industry is Limula Biotech in?

    Limula Biotech’s primary industry is Biotechnology.

  • Is Limula Biotech a private or public company?

    Limula Biotech is a Private company.

  • What is the current valuation of Limula Biotech?

    The current valuation of Limula Biotech is .

  • What is Limula Biotech’s current revenue?

    The current revenue for Limula Biotech is .

  • How much funding has Limula Biotech raised over time?

    Limula Biotech has raised $12M.

  • Who are Limula Biotech’s investors?

    Lichtsteiner Foundation, Life Extension Ventures, Oxford Saïd Business School, Verve Ventures, and W. A. de Vigier Foundation are 5 of 18 investors who have invested in Limula Biotech.

  • Who are Limula Biotech’s competitors?

    Cellares, Ori Biotech, Astraveus, MFX, and Adva Biotechnology are some of the 8 competitors of Limula Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process